Drawing for CGMAB

USPTO serial 88234725

CGMAB

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MAIHOS, JESSIE ANDREA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CGMAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Salvatore Guerriero

Salvatore Guerriero Ice Miller LLP1735 Market StreetSuite 3450Philadelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
042Research and development services in the field of antibodies; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; medical and scientific research in the field of cancer treatment and diagnosis; technical research in the field of pharmaceutical studies; research on the subject of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development; pharmaceutical products development; pharmaceutical product evaluation; development of pharmaceutical preparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical, biochemical, biological and bacteriological research and analysis; biological research; scientific study and research in the fields of medicine, the prevention, treatment and management of illness, health care delivery; technology research in the field of pharmaceutical research and development; research and development in the field of medicine, the prevention, treatment and management of illness, health care delivery; medical research; medical laboratories; medical and scientific research in the field of medicine, the prevention, treatment and management of illness, health care deliveryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Feb 1, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 1, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 20, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2020EX2GSOU EXTENSION 2 GRANTED—
May 18, 2020EXT2SOU EXTENSION 2 FILED—
May 18, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 23, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 23, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 23, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 19, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 17, 2019EX1GSOU EXTENSION 1 GRANTED—
Dec 17, 2019EXT1SOU EXTENSION 1 FILED—
Dec 17, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 25, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 30, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 30, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 15, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2019DOCKASSIGNED TO EXAMINER—
Jan 11, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance